[ Price : $8.95]
U.S., U.K. and Canadian drug regulators announce a joint international symposium to discuss evolving regulatory expectations for c...[ Price : $8.95]
FDA approves a Scancell Holdings IND to begin a registrational Phase 3 trial of iSCIB1+ in patients with advanced melanoma.[ Price : $8.95]
FDA says it continued to improve the speed and consistency of drug manufacturing oversight in fiscal year 2024, citing strong perf...[ Price : $8.95]
FDA cites Asahi Kasei Finechem Co. for significant quality control deficiencies following a November inspection of the companys ac...[ Price : $8.95]
FDAs annual report on drug approvals says the majority of novel drugs approved in 2025 moved through accelerated regulatory pathwa...[ Price : $8.95]
Advocacy groups urge Congress to advance legislation that would eliminate the statutory distinction between biosimilars and so-cal...[ Price : $8.95]
Sanofi says its experimental antibody amlitelimab showed consistent efficacy and a favorable safety profile across multiple late-s...[ Price : $8.95]
FDA approves Guardant Healths Guardant360 CDx liquid biopsy as a companion diagnostic to identify patients with BRAF V600Emutant m...